Cargando…
Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest
Background In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are wide...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
© Georg Thieme Verlag KG
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446142/ https://www.ncbi.nlm.nih.gov/pubmed/32572869 http://dx.doi.org/10.1055/a-1197-4293 |
_version_ | 1783574110009294848 |
---|---|
author | Reisinger, Emil C. von Possel, Ronald Warnke, Philipp Geerdes-Fenge, Hilte F. Hemmer, Christoph J. Pfefferle, Susanne Löbermann, Micha Littmann, Martina Emmerich, Petra |
author_facet | Reisinger, Emil C. von Possel, Ronald Warnke, Philipp Geerdes-Fenge, Hilte F. Hemmer, Christoph J. Pfefferle, Susanne Löbermann, Micha Littmann, Martina Emmerich, Petra |
author_sort | Reisinger, Emil C. |
collection | PubMed |
description | Background In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are widely closed. Methods Since the status of infection tends to be congruent in mothers and their children, we tested 401 mothers of children between 1 and 10 years in the city of Rostock (State of Mecklenburg-Westpomerania, northeast of Germany), for the presence of RNA of SARS-CoV-2 in throat swabs, and of antibodies against SARS-CoV-2 in serum. Results In none of the mothers tested, RNA of this virus was detected in the throat swab. In the ELISA test, IgG antibodies were positive in one serum sample, IgA antibodies were positive in 11, and borderline in 3 serum samples. All 401 sera were negative in the indirect immunofluorescence test (IIFT) with FITC-labeled IgG, IgA, und IgM antibodies. Conclusion At the time of this study, neither SARS-CoV-2 RNA, nor specific antibodies against SARS-CoV-2 were detectable in the mothers tested in Rostock. |
format | Online Article Text |
id | pubmed-7446142 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | © Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-74461422020-09-09 Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest Reisinger, Emil C. von Possel, Ronald Warnke, Philipp Geerdes-Fenge, Hilte F. Hemmer, Christoph J. Pfefferle, Susanne Löbermann, Micha Littmann, Martina Emmerich, Petra Dtsch Med Wochenschr Background In children, the infection with SARS-CoV-2, the cause of COVID-19, tends to be clinically inapparent more often or less severe than in adults. The spread of this infection from children poses a danger to vulnerable adults. Therefore, child care institutions and schools currently are widely closed. Methods Since the status of infection tends to be congruent in mothers and their children, we tested 401 mothers of children between 1 and 10 years in the city of Rostock (State of Mecklenburg-Westpomerania, northeast of Germany), for the presence of RNA of SARS-CoV-2 in throat swabs, and of antibodies against SARS-CoV-2 in serum. Results In none of the mothers tested, RNA of this virus was detected in the throat swab. In the ELISA test, IgG antibodies were positive in one serum sample, IgA antibodies were positive in 11, and borderline in 3 serum samples. All 401 sera were negative in the indirect immunofluorescence test (IIFT) with FITC-labeled IgG, IgA, und IgM antibodies. Conclusion At the time of this study, neither SARS-CoV-2 RNA, nor specific antibodies against SARS-CoV-2 were detectable in the mothers tested in Rostock. © Georg Thieme Verlag KG 2020-08 2020-06-22 /pmc/articles/PMC7446142/ /pubmed/32572869 http://dx.doi.org/10.1055/a-1197-4293 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Reisinger, Emil C. von Possel, Ronald Warnke, Philipp Geerdes-Fenge, Hilte F. Hemmer, Christoph J. Pfefferle, Susanne Löbermann, Micha Littmann, Martina Emmerich, Petra Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title | Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title_full | Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title_fullStr | Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title_full_unstemmed | Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title_short | Mütter-Screening in einem COVID-19-Niedrig-Pandemiegebiet: Bestimmung SARS-CoV-2-spezifischer Antikörper bei 401 Rostocker Müttern mittels ELISA und Immunfluoreszenz-Bestätigungstest |
title_sort | mütter-screening in einem covid-19-niedrig-pandemiegebiet: bestimmung sars-cov-2-spezifischer antikörper bei 401 rostocker müttern mittels elisa und immunfluoreszenz-bestätigungstest |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446142/ https://www.ncbi.nlm.nih.gov/pubmed/32572869 http://dx.doi.org/10.1055/a-1197-4293 |
work_keys_str_mv | AT reisingeremilc mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT vonposselronald mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT warnkephilipp mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT geerdesfengehiltef mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT hemmerchristophj mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT pfefferlesusanne mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT lobermannmicha mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT littmannmartina mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest AT emmerichpetra mutterscreeningineinemcovid19niedrigpandemiegebietbestimmungsarscov2spezifischerantikorperbei401rostockermutternmittelselisaundimmunfluoreszenzbestatigungstest |